logo-loader
FRA:B4V

Biotec Pharmacon

Receive alerts
Market:
FRA
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Biotec Pharmacon ASA is a biotechnology company developing, producing and marketing immune modulating beta-glucans and novel recombinant enzymes. The Company is organized into two business areas, each managed as a separate operating unit. The two groups are Biotec BetaGlucans AS and ArcticZymes AS.